Joanne M. Donovan is CMO of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 16,358 shares of EWTX, which is worth approximately $442,811. The most recent transaction as insider was on Jan 28, 2025, when has been sold 25,000 shares (Common Stock) at a price of $27.63 per share, resulting in proceeds of $690,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.4K
12.52% 3M change
64.24% 12M change
Total Value Held $442,811

Joanne M. Donovan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2025
SELL
Open market or private sale
$690,750 $27.63 p/Share
25,000 Reduced 60.45%
16,358 Common Stock
Jan 28 2025
BUY
Exercise of conversion of derivative security
$177,000 $7.08 p/Share
25,000 Added 37.67%
41,358 Common Stock
Sep 20 2024
SELL
Open market or private sale
$202,612 $28.29 p/Share
7,162 Reduced 33.0%
14,538 Common Stock
May 02 2024
SELL
Open market or private sale
$69,626 $18.91 p/Share
3,682 Reduced 15.62%
19,897 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
10,417 Added 30.64%
23,579 Common Stock
May 02 2023
SELL
Open market or private sale
$28,960 $8.9 p/Share
3,254 Reduced 24.63%
9,960 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
-
10,416 Added 44.08%
13,214 Common Stock
JMD

Joanne M. Donovan

CMO
Boulder, CO

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX